SciSparc subsidiary NeuroThera Labs’ quantum platform completes end-to-end hybrid workflow for clinical data analytics

Reuters2026/07/31 12:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

SciSparc unit NeuroThera reached a milestone in its quantum sampling platform for clinical-trial data analytics.
Platform ran an end-to-end hybrid quantum-classical workflow in a quantum simulation environment, from secure data ingestion to interpretable clinical insights.
Development plan targets larger dataset support, quantum algorithm optimization, and performance studies for clinical research analytics.
Platform is advanced through CliniQuantum, a quantum-focused initiative majority-owned by NeuroThera at 54.01%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310820PRIMZONEFULLFEED9801605) on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

SciSparc subsidiary NeuroThera Labs’ quantum platform completes end-to-end hybrid workflow for clinical data analytics

You may also like

Crypto prices